Cargando…
Prevention of gastric cancer by Helicobacter pylori eradication: A review from Japan
Japan introduced a Helicobacter pylori eradication therapy strategy in 2013, with the aim of decreasing the number of gastric cancer‐related death, the number of new cases of gastric cancer, and associated medical costs. Five years have passed since then, but no reduction in the annual number of gas...
Autor principal: | Uno, Yoshiharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639173/ https://www.ncbi.nlm.nih.gov/pubmed/31119891 http://dx.doi.org/10.1002/cam4.2277 |
Ejemplares similares
-
“Latent Gastric Cancer” after Eradicating Helicobacter pylori
por: Uno, Yoshiharu
Publicado: (2018) -
Helicobacter pylori‐related risk predictors of gastric cancer: The latest models, challenges, and future prospects
por: Bakhti, Seyedeh Zahra, et al.
Publicado: (2020) -
Inverse association of Helicobacter pylori cagPAI genotypes with risk of cardia and non‐cardia gastric adenocarcinoma
por: Bakhti, Seyedeh Zahra, et al.
Publicado: (2019) -
Additive interactions between PRKAA1 polymorphisms and Helicobacter pylori CagA infection associated with gastric cancer risk in Koreans
por: Eom, Sang‐Yong, et al.
Publicado: (2016) -
Prevention of Gastric Cancer: Eradication of Helicobacter pylori and Beyond
por: Tsukamoto, Tetsuya, et al.
Publicado: (2017)